Literature DB >> 29213774

Acquired hepatocerebral degeneration: A case report.

Clarice Listik1, Gislaine Cristina Lopes Machado-Porto2, Maira Okada de Oliveira3, Fábio Henrique de Gobbi Porto4.   

Abstract

Acquired hepatocerebral degeneration is an underdiagnosed neurologic syndrome characterized by parkinsonism, ataxia or other movement disorders and by neuropsychiatric and cognitive symptoms. It occurs in patients with chronic liver disease, especially those who develop portosystemic shunting and is often unrecognized as a cause of cognitive decline. Recently, its pathogenesis has been associated with manganese accumulation in basal ganglia and some treatments proposed. The aim of this article was to report a case and discuss some discoveries in connection with the disease.

Entities:  

Keywords:  acquired hepatocerebral degeneration; hepatic encephalopathy; liver disease

Year:  2012        PMID： 29213774      PMCID： PMC5619109          DOI： 10.1590/S1980-57642012DN06010010

Source DB:  PubMed          Journal:  Dement Neuropsychol        ISSN： 1980-5764


  28 in total

1.  [Suggestions for utilization of the mini-mental state examination in Brazil].

Authors:  Sonia M D Brucki; Ricardo Nitrini; Paulo Caramelli; Paulo H F Bertolucci; Ivan H Okamoto
Journal:  Arq Neuropsiquiatr       Date:  2003-10-28       Impact factor: 1.420

2.  Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration.

Authors:  Hee K Park; Seung M Kim; Choong G Choi; Myoung C Lee; Sun J Chung
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

Review 3.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 4.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

5.  Chronic acquired hepatocerebral degeneration: case reports and new insights.

Authors:  M S Jog; A E Lang
Journal:  Mov Disord       Date:  1995-11       Impact factor: 10.338

6.  Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

Authors:  C Rose; R F Butterworth; J Zayed; L Normandin; K Todd; A Michalak; L Spahr; P M Huet; G Pomier-Layrargues
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

7.  Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations.

Authors:  Eiji Matsusue; Toshibumi Kinoshita; Eisaku Ohama; Toshihide Ogawa
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

Review 8.  Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy.

Authors:  R F Butterworth; L Spahr; S Fontaine; G P Layrargues
Journal:  Metab Brain Dis       Date:  1995-12       Impact factor: 3.584

9.  Cognitive functioning in chronic acquired hepatocerebral degeneration.

Authors:  Andrea Stracciari; Katia Mattarozzi; Roberto D'Alessandro; Elisa Baldin; Maria Guarino
Journal:  Metab Brain Dis       Date:  2008-04-24       Impact factor: 3.584

10.  Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study.

Authors:  S Bellentani; C Tiribelli; G Saccoccio; M Sodde; N Fratti; C De Martin; G Cristianini
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.